Oliver Moravcevic

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when RxSight, Inc. publishes a filing, an earnings call transcript or a press release.

Get RXST alerts

About Oliver Moravcevic

Oliver Moravcevic is recorded as Head of Investor Relations at RxSight, Inc. (RXST). Oliver Moravcevic has spoken on 9 earnings calls and 1 other investor event across 1 company, most recently for RxSight, Inc. on August 5, 2026. RxSight, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at RxSight, Inc. includes Aziz Mottiwala (CEO and Board Member), Ron Kurtz (CEO and Board Member), Mark Wilterding (CFO) and 4 others.

Oliver Moravcevic on recent calls

“With me on the call today are RSI President and Chief Executive Officer Aziz Motibala and Chief Financial Officer Mark Wolterding. Earlier today, RSI had released financial results for the three months ended June 30, 2026.”

Head of Investor Relations, RxSight Second Quarter 2026 Earnings Conference Call · August 5, 2026

“With me on the call this morning is RxSight President and Chief Executive Officer, Dr. Ron Kurtz, and Chief Financial Officer, Mark Wilterdy.”

Head of Investor Relations, RXST Conference Call · July 7, 2026

“With me on the call today are RxSight President and Chief Executive Officer Dr. Ron Kurtz and Chief Financial Officer Mark Wilterding. Earlier today, RxSight released financial results for the three months ended March 31, 2026.”

Head of Investor Relations, RxSight, Inc. Q1 FY2026 Earnings Call · May 6, 2026

“Presenting today are RSI President and Chief Executive Officer, Dr. Ron Kurtz, and Chief Financial Officer, Mark Wolterding. Earlier today, RSI released financial results for the three months ended December 31st, 2025.”

Head of Investor Relations, RxSight, Inc. Q4 FY2025 Earnings Call · February 25, 2026

“Presenting today are RxSight President and Chief Executive Officer, Dr. Ron Kurtz, and Chief Financial Officer, Shally Tunin. Earlier today, RxSight released its financial results for the three months ending September 30, 2025, and updated its full year guidance.”

Head of Investor Relations, RxSight, Inc. Q3 FY2025 Earnings Call · November 5, 2025